Latest News

MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator

April 23, 2024

Brussels, 23 April 2024 – Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy…

Q&A: US Food and Drug Administration (FDA) approves MRD as a basis for accelerated approval in myeloma

April 18, 2024

Last Friday, the US FDA’s Oncology Drugs Advisory Committee (ODAC) (FDA being the US medicines regulator) voted 12 – 0 to approve minimal residual disease (MRD) as an accepted endpoint for accelerated approval of new myeloma…

MPE gives feedback on the proposed implementing act supporting the EU Health Technology Assessment regulation

April 8, 2024

The European Commission recently held an online public consultation on the first draft implementing act supporting the EU health technology assessment (HTA) regulation. The EU HTA regulation will be implemented from 2025 and aims to…

Sign up for the MPE webinar “AL amyloidosis treatment updates and patient experiences on new therapies”

March 27, 2024

Myeloma Patients Europe (MPE) will hold the webinar “AL amyloidosis treatment updates and patient experiences on new therapies” on Tuesday 16 April from 17:00 – 18:00 CEST. The webinar will be given by Dr. Moshe Gatt, Physician Researcher…

Snežana Doder, young myeloma patient: “When I talk about my journey, I compare it to a roller coaster. Everything happened very fast and unexpectedly”

March 25, 2024

My name is Snežana Doder and I´m from Serbia. When I talk about my journey, I compare it to a roller coaster. Everything happened very fast and unexpectedly. I had a very healthy lifestyle…

Ana Rocha, young myeloma patient: “I didn’t let the diagnosis change me and I thought I should build something to help others newly diagnosed”

March 8, 2024

After the diagnosis, it took almost a month to start the treatments. The first one was on my birthday, and I felt that the universe was giving me a unique opportunity. I did six cycles…

US FDA approves bi-weekly teclistamab dosing in relapsed/refractory myeloma

February 22, 2024

The US Food and Drug Administration (FDA – the medicines regulator in the US) has granted approval to a “supplemental biologics license application” for teclistamab-cqvy (Tecvayli®). This means the existing FDA teclistamab license has been extended to…

AMEN provides medical information for Arabic speakers in Israel and beyond

February 13, 2024

The population of Israel today is 9.8 million people. Among them, 20% are Arabs (about 2 million people) whose first language is Arabic. Due to this, the Israel Multiple Myeloma Association, AMEN, decided to promote…

September

October 2025

November

MO
TU
WE
TH
FR
SA
SU

29
30
1
2
3
4
5

6
7
8
9
10
11
12

13
14
15
16
17
18
19

20
21
22
23
24
25
26

27
28
29
30
31
1
2

Events for October

31st

No Events

Latest News

October 2025

Events for October

1st

Events for October

2nd

Events for October

3rd

Events for October

4th

Events for October

5th

Events for October

6th

Events for October

7th

Events for October

8th

Events for October

9th

Events for October

10th

Events for October

11th

Events for October

12th

Events for October

13th

Events for October

14th

Events for October

15th

Events for October

16th

Events for October

17th

Events for October

18th

Events for October

19th

Events for October

20th

Events for October

21st

Events for October

22nd

Events for October

23rd

Events for October

24th

Events for October

25th

Events for October

26th

Events for October

27th

Events for October

28th

Events for October

29th

Events for October

30th

Events for October

31st

PopUp